ao link
Who's Who Legal
Who's Who Legal
Menu
Thought Leaders

Thought Leaders

Thought Leader

WWL Ranking: Global Elite Thought Leader
Thought Leaders Global Elite - Trademarks
WWL Ranking: Global Elite Thought Leader

Global Leader

WWL Ranking: Global Elite Thought Leader
WWL Ranking: Global Elite Thought Leader
WWL Ranking: Recommended

WWL says

Morag Macdonald is "a robust life sciences litigator", highly sought after for her outstanding work on domestic and international patent disputes. 

Biography

Morag Macdonald offers clients impressive depth of experience and a solutions orientated approach to their disputes and cross-border patent work.

Morag is joint head of the international intellectual property group and is regularly named as a leader in the  IP  and  particularly the  patent field internationally. Her particular interests are all forms of IP disputes and strategic advice, especially in regards to international cross-border IP strategy advice.

Reported UK IP trials in which she has been involved include Mentor v Hollister, Research Corporation’s SPC, Reckitt & Coleman v Richardson Vicks, Cartonneries de Thulin v White Knight, Stolt Comex Seaway ats Coflexip, Freelift v Stannah, Synthon v SKB, Associated Newspapers v  Express Newspapers, Sir Robert McAlpine v  Alfred McAlpine, Allergan v  Merz Pharma, Baxter Healthcare v Abbott Laboratories, European Central Bank v DSS, Edwards Lifesciences v Corevalve and more recently Kuros Biosurgery AG v Baxter Healthcare, Schlumberger Holdings Limited v Electromagnetic Geoservices AS, Danisco A/S v Novozymes A/S, Smith & Nephew Plc v Convatec Technologies Inc, Virgin Atlantic Airways Ltd v Air Canada and Velocys Inc v CompactGTL Ltd.

In recent years she has had particular involvement in the coordination and running of various pan-European patent actions involving several jurisdictions  in  Europe,  not always including the United Kingdom. For example, the patent litigation between Baxter  v Pharmacia &  Upjohn/Genetics Institute (in the Netherlands, Sweden, Germany and before the ICC), between NovoNordisk v DSM (in the UK, Belgium, the Netherlands and Germany), between GlaxoWellcome ats Hoffmann-La Roche (in Belgium and Germany) and between JCB v Manitou (in the UK and France), for Allergan (in the UK, the Netherlands and Sweden), Halliburton v Smith (in the UK and Italy), Edwards Lifesciences v Cook Biotech (in the UK and Germany) and Fisher & Paykel v ResMed (in the UK, Germany, the US, Australia and New Zealand).

She acted in the first community design right case to come to trial in Europe, Mattel v Simba acting for the successful claimant. She has also been involved in  a  number of other design rights disputes including acting for Reckitt Benckiser in Procter & Gamble v Reckitt Benckiser.

As well as IP litigation, she has been the lead advocate in major cross-border biotech arbitration, provided freedom to operate advice in the field of carbon capture and advised a financial services company on its patent strategy in over 40 jurisdictions. Morag is highly regarded by both clients and peers, and she is often applauded for her "common sense, goal-orientated and no-nonsense approach".

She joined Bird & Bird’s intellectual property group in 1985 having originally trained as a barrister and became a partner of the firm in 1989. Her original degree, from Cambridge University, was in mathematics, physics and law.
Law Business Research
Law Business Research Ltd
Meridian House, 34-35 Farringdon Street
London EC4A 4HL, UK
© Law Business Research Ltd 1998-2021. All rights reserved.
Company No.: 03281866